Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma

Low-grade brain tumors (pilocytic astrocytomas) arising in the neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome are hypothesized to result from a combination of germline and acquired somatic NF1 tumor suppressor gene mutations. However, genetically engineered mice (GEM) in which mono-allelic germline Nf1 gene loss is coupled with bi-allelic somatic (glial progenitor cell) Nf1 gene inactivation develop brain tumors that do not fully recapitulate the neuropathological features of the human condition. These observations raise the intriguing possibility that, while loss of neurofibromin function is necessary for NF1-associated low-grade astrocytoma development, additional genetic changes may be required for full penetrance of the human brain tumor phenotype. To identify these potential cooperating genetic mutations, we performed whole-genome sequencing (WGS) analysis of three NF1-associated pilocytic astrocytoma (PA) tumors. We found that the mechanism of somatic NF1 loss was different in each tumor (frameshift mutation, loss of heterozygosity, and methylation). In addition, tumor purity analysis revealed that these tumors had a high proportion of stromal cells, such that only 50%–60% of cells in the tumor mass exhibited somatic NF1 loss. Importantly, we identified no additional recurrent pathogenic somatic mutations, supporting a model in which neuroglial progenitor cell NF1 loss is likely sufficient for PA formation in cooperation with a proper stromal environment.

[1]  H. Kapfhammer,et al.  Higher psychological and psychovegetative strain in adolescents with atypical pigment naevi. , 2015, Acta dermato-venereologica.

[2]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[3]  Steven J. M. Jones,et al.  BreakFusion: targeted assembly-based identification of gene fusions in whole transcriptome paired-end sequencing data , 2012, Bioinform..

[4]  D. Gutmann,et al.  Innate neural stem cell heterogeneity determines the patterning of glioma formation in children. , 2012, Cancer cell.

[5]  Joshua F. McMichael,et al.  Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition , 2012, Nature.

[6]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[7]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[8]  Joshua F. McMichael,et al.  Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.

[9]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[10]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[11]  Michael C. Rusch,et al.  CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.

[12]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[13]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[14]  J. Payton,et al.  Genome‐wide polymorphism analysis demonstrates a monoclonal origin of pilocytic astrocytoma , 2011, Neuropathology and applied neurobiology.

[15]  Stella E Tsirka,et al.  Microglia/macrophages promote glioma progression , 2011, Glia.

[16]  D. Gutmann,et al.  Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially and Temporally Restricted Pattern Relevant to Mouse Optic Glioma Formation and Growth , 2011, Journal of neuropathology and experimental neurology.

[17]  D. Gutmann,et al.  Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner. , 2010, Genes & development.

[18]  Mark Ellisman,et al.  Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma , 2010, Neuroscience.

[19]  N. Warrington,et al.  Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. , 2010, Cancer research.

[20]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[21]  T. Kiehl,et al.  Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings , 2010, Journal of Cancer Research and Clinical Oncology.

[22]  Zachary D. Smith,et al.  Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution , 2010, Nature Methods.

[23]  Amos Bairoch,et al.  PROSITE, a protein domain database for functional characterization and annotation , 2009, Nucleic Acids Res..

[24]  A. Órfão,et al.  Intratumoral patterns of clonal evolution in gliomas , 2010, neurogenetics.

[25]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[26]  R. Wilson,et al.  BreakDancer: An algorithm for high resolution mapping of genomic structural variation , 2009, Nature Methods.

[27]  Kai Ye,et al.  Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..

[28]  D. Gutmann,et al.  Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. , 2008, Cancer research.

[29]  David T. W. Jones,et al.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. , 2008, Cancer research.

[30]  M. Watson,et al.  High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas , 2008, Oncogene.

[31]  G. Reifenberger,et al.  BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. , 2008, The Journal of clinical investigation.

[32]  A. Wesołowska,et al.  Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor , 2008, Oncogene.

[33]  N. Warrington,et al.  Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1. , 2007, Cancer research.

[34]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[35]  D. Gutmann,et al.  Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. , 2007, Human molecular genetics.

[36]  Arie Perry,et al.  Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. , 2007, Cancer research.

[37]  A. King,et al.  The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1 , 2006, Neurology.

[38]  D. Gutmann,et al.  Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation , 2005, Development.

[39]  M. Watson,et al.  RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma , 2005, Neurology.

[40]  Behnam Badie,et al.  Microglia function in brain tumors , 2005, Journal of neuroscience research.

[41]  M. Wallace,et al.  Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells. , 2005, Cancer genetics and cytogenetics.

[42]  D. Gutmann,et al.  Natural history of neurofibromatosis 1–associated optic nerve glioma in mice , 2005, Annals of neurology.

[43]  A. von Deimling,et al.  Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. , 2004, European journal of cancer.

[44]  R. Tenconi,et al.  Neurofibromatosis-1: a maximum likelihood estimation of mutation rate , 2004, Human Genetics.

[45]  D. Gutmann,et al.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. , 2003, Cancer research.

[46]  C. James,et al.  Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1 , 2003, Neurology.

[47]  J. Kuratsu,et al.  Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1. , 2003, Neuro-oncology.

[48]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[49]  B. Scheithauer,et al.  Microglia in brain tumors , 2002, Glia.

[50]  K. Wimmer,et al.  Mutational and Expression Analysis of the NF1 Gene Argues Against a Role as Tumor Suppressor in Sporadic Pilocytic Astrocytomas , 2002, Journal of neuropathology and experimental neurology.

[51]  D. Gutmann,et al.  Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.

[52]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[53]  T. Dóczi,et al.  Microsatellite Analysis of Primary and Recurrent Glial Tumors Suggests Different Modalities of Clonal Evolution of Tumor Cells , 2002, Journal of neuropathology and experimental neurology.

[54]  H. Ng,et al.  Clonality of oligoastrocytomas. , 2002, Human pathology.

[55]  R. Kuick,et al.  Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma , 2002, Genes, chromosomes & cancer.

[56]  M. Tatagiba,et al.  Loss of NF1 Alleles Distinguish Sporadic from NF1‐Associated Pilocytic Astrocytomas , 2001, Journal of neuropathology and experimental neurology.

[57]  C. James,et al.  Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas , 2001, Neurology.

[58]  A. Deimling,et al.  Clonal Analysis in Glioblastoma with Epithelial Differentiation , 2001, Brain pathology.

[59]  D. Gutmann,et al.  Loss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas , 2000, Neuropathology and applied neurobiology.

[60]  D. Cooper,et al.  Hypermethylation of the neurofibromatosis type 1 (NF1) gene promoter is not a common event in the inactivation of the NF1 gene in NF1-specific tumours , 2000, Human Genetics.

[61]  F. Sarkar,et al.  Clonal analysis of gliomas. , 1997, Human pathology.

[62]  R. Folkerth,et al.  Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas. , 1997, The American journal of pathology.

[63]  D. Louis,et al.  Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. , 1997, Annals of neurology.

[64]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[65]  J. Charrow,et al.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.

[66]  S. Huson,et al.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. , 1989, Journal of medical genetics.

[67]  S. Huson,et al.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. , 1989, Journal of medical genetics.

[68]  B. Ponder,et al.  NEUROFIBROMATOSIS , 1988, The Lancet.

[69]  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.

[70]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[71]  B. Samuelsson,et al.  Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden. , 1981, Acta dermato-venereologica. Supplementum.

[72]  W. Schull,et al.  A clinical, pathological, and genetic study of multiple neurofibromatosis , 1956 .